Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks?
Self
Timothy
T
College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA. tself@utmem.edu
Soberman
Judith E
JE
Bubla
Jamie M
JM
Chafin
Carol C
CC
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001249:Asthma / Q000150:complications*; D001986:Bronchial Spasm / Q000139:chemically induced* / Q000188:drug therapy; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D012720:Severity of Illness Index
D000319:Adrenergic beta-Antagonists